Kelleher Financial Advisors’s ELITE PHARMACEUTICAL ELI Stock Holding History

Kelleher Financial Advisors’s Portfolio ELI Stock Details ELI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$365	Buy	1,000 +500	+100%	+$183	﹤0.01%	846
2026 Q1	$180	Hold	500	–	–	﹤0.01%	679
2025 Q4	$245	Hold	500	–	–	﹤0.01%	697
2025 Q3	$320	Buy	+500	New	+$320	﹤0.01%	632

Kelleher Financial Advisors's ELI Position: Q2 2026 in Review

Kelleher Financial Advisors increased its ELITE PHARMACEUTICAL (ELI) stake by 100% in Q2 2026, buying an estimated $183 and bringing the position to 1,000 shares worth $365. The position accounts for ﹤0.01% of the portfolio, ranked #846.

Kelleher Financial Advisors first reported a position in ELI in Q3 2025 and has held it in 4 quarters since. 1 fund tracked by Wall St. Rank holds ELI as of Q2 2026.

Kelleher Financial Advisors held 1,000 shares of ELITE PHARMACEUTICAL worth $365 as of Q2 2026.
Kelleher Financial Advisors bought 500 ELITE PHARMACEUTICAL shares in Q2 2026, an estimated $183.
ELITE PHARMACEUTICAL made up ﹤0.01% of Kelleher Financial Advisors's portfolio in Q2 2026, its #846 holding.
Kelleher Financial Advisors first reported a position in ELITE PHARMACEUTICAL in Q3 2025 and has held it in 4 quarters since.
1 fund tracked by Wall St. Rank held ELITE PHARMACEUTICAL as of Q2 2026.

Based on Kelleher Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.